Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.China Biologic Products has named Stanley Lau as the new president of the company, effective 1 December 2010.
Subscribe to our email newsletter
As president of the company, Lau will oversee strategic planning and business development, partnership management and organisation development.
Prior to joining China Biologic, Lau served from 2002 to 2009, in various executive roles at Baxter Health International, including as general manager of Baxter Healthcare (Hong Kong), Baxter’s wholly-owned subsidiary, where he oversaw four joint ventures and a 500% increase in revenue in less than four years.
Lau also worked for Pfizer and for Pharmacia, Merck & Co, where he established Merck’s first wholly-owned subsidiary in Taiwan.
China Biologic CEO Chao Ming Zhao said that they are extremely pleased to welcome executive of Lau’s caliber to their team.
"We believe that his broad and deep experience within the pharmaceutical industry brings an enhanced global perspective and expertise to our organisation," Zhao said.